Patents Examined by Stephen Chong
-
Patent number: 9446100Abstract: Provided are dietary supplements, formulations, kits and methods for administration to an individual with type II diabetes or at risk of developing type II diabetes. Provided herein are formulations, kits and methods useful for treating, preventing, supporting, controlling, restoring, and/or maintaining blood sugar levels in individuals with type II diabetes or at risk of developing the same. Also provided are formulations, kits and methods useful for reducing and/or eliminating requirement of ex-vivo insulin administration in an individual diagnosed with type II diabetes.Type: GrantFiled: March 18, 2015Date of Patent: September 20, 2016Assignee: EASTERN VISION LIMITEDInventors: Michael Holstein, Eric Huntington
-
Patent number: 9441197Abstract: Methods of inducing or increasing lipid and protein production in microalgae are disclosed. Methods of enhancing microalgae biomass are also disclosed. The methods may comprise inoculating a culture media with microalgae and propagating the microalgae under heterotrophic growth conditions. The heterotrophic growth conditions may comprise inhibiting exposure of the inoculated culture media to light. The methods may further comprise delivering oxygen into the inoculated culture media. Additionally, lipids, proteins, and other cellular components may be isolated and purified from microalgae cultivated under the disclosed methods.Type: GrantFiled: April 30, 2015Date of Patent: September 13, 2016Assignee: ENTECH, LLCInventors: John Whitman, Robert G. Barton, Michael Ripka, III, Michael Ripka, Jr., Robert L. Harris
-
Patent number: 9433727Abstract: Tissue rejuvenation methods include identifying a cell harvest site on a patient, identifying a cell injection site on the patient, harvesting tissue regenerative cells from the cell harvest site, agitating the tissue regenerative cells and injecting the tissue regenerative cells into the cell injection site. Tissue transfer devices suitable for implementation of the tissue rejuvenation methods are also disclosed.Type: GrantFiled: February 5, 2014Date of Patent: September 6, 2016Inventor: Simeon Wall, Jr.
-
Patent number: 9434899Abstract: The invention relates to the preparation of carboxylic acid esters compounds, biodiesel (B) from microalgae, for use as a biofuel for compression type ignition. The objective is achieved through a hydroesterification process of a microalgae biomass (MU) comprising a hydrolysis stage and the esterification stage by means of heterogeneous catalysis. The wet microalgae biomass (MU) is the result of a process of cultivation concentration and is hydrolyzed directly in a hydrolysis column (20). Fatty acids (C), water (A) and raw glycerin (G) are obtained following the hydrolysis. The fatty acids (C) are esterified by reactive distillation in the presence of an impregnated heterogeneous catalyst (I).Type: GrantFiled: November 28, 2012Date of Patent: September 6, 2016Assignees: PETROLEO BRASILEIRO S.A—PETROBRAS, UNIVERSIDADE FEDERAL DO RIO DE JANEIRO—UFRJInventors: Donato Alexandre Gomes Aranda, Yordanka Reyes Cruz, Gisel Chenard Dias, Leonardo Brantes Bacellar Mendes, Rafael Richard Joao
-
Patent number: 9410970Abstract: A triple sensor structured for simultaneous measurement of glucose, oxygen, and pH. The sensor components are in thin film states such as sensing films or membranes, with a glucose probe associated with emission of radiation in the blue part of the spectrum, an oxygen probe associated with radiation in red portion of the spectrum, and a pH probe—with a green portion of the spectrum. The optical probes are chemically grafted or immobilized in a suitable polymer matrix, alleviating the leaching of the probes from the matrix, improving the thin film sensing stability, and enabling the repeatable use of the same sensing films.Type: GrantFiled: November 5, 2014Date of Patent: August 9, 2016Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITYInventors: Yanqing Tian, Liqiang Zhang, Fengyu Su, Deirdre Meldrum, Sean Buizer, Clifford L. Anderson, Laimonas Kelbauskas, Kristen Lee
-
Patent number: 9394512Abstract: The method of growing the basidiomycete mycelium includes inoculating a substrate that promotes the growth and differentiation of basidiomycete mycelium without supporting the production of a basidiocarp with a vegetative mycelium and thereafter incubating the inoculated substrate in a first incubation period at controlled temperature, humidity, light and carbon dioxide levels followed by a finishing incubation period.Type: GrantFiled: May 14, 2015Date of Patent: July 19, 2016Assignee: ECOVATIVE DESIGN LLCInventors: Eben Bayer, Gavin R. McIntyre
-
Patent number: 9372183Abstract: A method is provided for the discrimination of cells from other particles, as well as of different types of cells in raw milk samples by impedance microflow cytometry. A method is provided of analysing the quality of raw milk in terms of its bacterial and somatic cell content without the need to pre-treat the milk sample, such that the analysis can take place directly at the production site. One advantage is discriminating and counting somatic cells from milk particles (consisting mainly of lipid vesicles) by high-frequency impedance analysis directly performed on untreated raw milk. Another advantage is that the method allows diagnosing the status of a mastitis infection directly after milking according to the analysis of the somatic cell count. Another advantage is to allow a fast method for determining the bacterial cell count in raw milk directly after milking. In addition, viability of both somatic and bacterial cells can be determined without the need of any cell label.Type: GrantFiled: December 23, 2014Date of Patent: June 21, 2016Assignee: Amphasys AGInventors: Marco Di Berardino, Grit Schade-Kampmann
-
Patent number: 9365869Abstract: A process for increasing a production of alcohol by fermenting sugars may include applying a direct current electrical field to a fermentation broth, which occurs before the fermentation broth inoculates with a concentration of yeasts; and controlling a pH value of said fermentation broth to maintain the pH value with a specific range.Type: GrantFiled: July 24, 2013Date of Patent: June 14, 2016Assignee: ADVEL TECNOLOGIA E COMERCIA LTDA.Inventor: José Francisco Lopes
-
Patent number: 9340821Abstract: A pseudo-esterase activity-based fluorescent probe for specific detection of albumin, which has a carboxylic ester bond that can be selectively cleaved by human serum albumin (HSA), therefore forming a hydrolysate, which has a fluorescence emission spectrum significantly different from that of the fluorescent probe. According to the fluorescence intensity of the fluorescent probe and hydrolysate, we can detect the content of HSA in a biological sample.Type: GrantFiled: March 27, 2014Date of Patent: May 17, 2016Assignee: DALIAN INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCESInventors: Ling Yang, Jingnan Cui, Guangbo Ge, Zhaoming Liu, Lei Feng
-
Patent number: 9320766Abstract: The Lactobacillus plantarum CCFM8661 is tolerant to acid and lead ions in vitro which can tolerate lead ions solution with the initial concentration of 150 mg/L, and has a strong capability of binding lead ions, which can reduce the lead level in mice blood, liver, kidney and stomach, significantly improve antioxidant indicators and alleviate pathological symptoms of lead exposed mice.Type: GrantFiled: July 18, 2012Date of Patent: April 26, 2016Assignee: Jiangnan UniversityInventors: Fengwei Tian, Wei Chen, Qixiao Zhai, Hao Zhang, Jianxin Zhao, Gang Wang, Yuanda Song, Qiuxiang Zhang, Xiaoming Liu, Min Guo, Daming Fan
-
Patent number: 8871476Abstract: A microbial consortium comprises of an Aureobasidium sp. to metabolise a sugar substrate into fructooligosaccaride, glucose and fructose and a Pachysolen sp to metabolise the glucose and the fructose into ethanol.Type: GrantFiled: October 11, 2010Date of Patent: October 28, 2014Assignee: TATA Chemicals LimitedInventors: Manoj Gote, Ganapathi Patil, Maheswaran Palamalai, Saravanan Rengarajan, Uday Kashinath Avalakki
-
Patent number: 8809050Abstract: An improved method of culturing cells for cell therapy applications that includes growing desired cells in the presence of antigen-presenting cells and/or feeder cells and with medium volume to surface area ratio of up to 1 ml/cm2 if the growth surface is not comprised of gas permeable material and up to 2 ml/cm2 if the growth surface is comprised of gas permeable material. The desired cells are at a surface density of less than 0.5×106 cells/cm2 at the onset of a production cycle, and the surface density of the desired cells plus the surface density of the antigen presenting cells and/or feeder cells are at least about 1.25×105 cells/cm2.Type: GrantFiled: December 8, 2010Date of Patent: August 19, 2014Assignee: Wilson Wolf ManufacturingInventors: Juan F. Vera, Cliona M Rooney, Ann M. Leen, John R. Wilson
-
Patent number: 8802409Abstract: Oleaginous yeast strains are used to hydrolyze biomass (e.g. wheat straw) that has been pretreated using dilute acid, in order to produce lipids. The lipids may be used as feedstock for producing biofuels.Type: GrantFiled: September 6, 2011Date of Patent: August 12, 2014Assignee: Washington State UniversityInventors: Xiaochen Yu, Yubin Zheng, Shulin Chen
-
Patent number: 8790640Abstract: The teachings provided herein generally relate to site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites. More particularly, the systems taught here include a phenolic compound bound to a reactive oxygen species, wherein the phenolic compound and the reactive oxygen species react at a target area in the presence of an oxidoreductase enzyme.Type: GrantFiled: March 10, 2014Date of Patent: July 29, 2014Assignee: LiveLeaf, Inc.Inventors: Alexander L Huang, Gin Wu
-
Patent number: 8778332Abstract: Provided is an agent or a food or drink for reducing the risk of developing breast cancer. An agent for reducing the risk of developing breast cancer which comprises a composition containing living cells of Lactobacillus casei.Type: GrantFiled: October 21, 2010Date of Patent: July 15, 2014Assignee: Kabushiki Kaisha Yakult HonshaInventors: Masakazu Toi, Yasuo Ohashi
-
Patent number: 8778679Abstract: Human umbilical cord lining stem cells that are capable of differentiating into cells of the mesodermal lineage and ectodermal lineage are described, as well as methods of isolating, expanding, culturing, and cryopreserving such cells.Type: GrantFiled: November 2, 2012Date of Patent: July 15, 2014Assignee: DaVinci Biosciences LLCInventors: Francisco J. Silva, Rafael Gonzalez
-
Patent number: 8771679Abstract: The present invention features a novel protein engineering strategy by combining the domains of two independent proteins into a molecular switch. The invention features polypeptides comprising a prodrug activating enzyme and a protein that binds a cancer specific marker, polynucleotides encoding the polypeptides, and molecular switches for converting a prodrug into a toxin, comprising the polypeptides. The invention also features methods for converting a prodrug into a toxin, methods for treating cancer, and methods for making the molecular switches, as well as kits.Type: GrantFiled: August 13, 2009Date of Patent: July 8, 2014Assignee: The John Hopkins UniversityInventors: Marc Alan Ostermeier, Chapman M. Wright
-
Patent number: 8759100Abstract: This invention provides a means for modifying surface properties of a cell culture substrate under specific conditions, to thereby regulate regions to which cells are allowed to adhere or are not allowed to adhere, depending on cell type. This invention relates to a method of cell culture comprising steps of: applying a positive potential to a conductive region of a substrate comprising a base material having a conductive region and a non-cell-adhesive membrane coupled thereto with the aid of silane, so as to separate the non-cell-adhesive membrane from the substrate; and culturing cells in a region from which the non-cell-adhesive membrane has been separated.Type: GrantFiled: December 6, 2010Date of Patent: June 24, 2014Assignee: Dai Nippon Printing Co., Ltd.Inventors: Naoki Yokoyama, Tomonori Akai
-
Patent number: 8753807Abstract: Treatment methods/devices are provided for attenuating/inactivating the pathogenic microbes found in biological fluids e.g. blood/blood products including human single-donor-fresh-frozen-plasma, platelet concentrate, red blood cells, blood clotting factors. An Antimicrobial Photodynamic Therapy method is used to eliminate multiple (resistant) bacteria, viral agents, fungi, parasites and other undetected or non-easily detected pathogenic microbes or particles in blood and blood products without affecting their biological properties. Resistant bacteria are difficult to be eliminated. This is especially true in the case for S. aureus and related strains, Staphylococcus epidermidis or Propionibacterium acnes, Borrelia species and other bacteria found on skin. Further embodiments eliminate undetected or non-easily detected viral agents contaminating blood/blood products responsible for spreading hepatitis, Acquired ImmunoDeficiency Syndrome and other blood borne viral diseases.Type: GrantFiled: June 2, 2010Date of Patent: June 17, 2014Assignee: Biolitec Pharma Marketing LtdInventors: Gerhard D. Wieland, Albrecht Volker, Karl-Heinz Völpel, Burkhard Gitter
-
Patent number: 8722040Abstract: The teachings provided herein generally relate to site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites. More particularly, the systems taught here include a phenolic compound bound to a reactive oxygen species, wherein the phenolic compound and the reactive oxygen species react at a target area in the presence of an oxidoreductase enzyme.Type: GrantFiled: June 24, 2011Date of Patent: May 13, 2014Assignee: Liveleaf, Inc.Inventors: Alexander L. Huang, Gin Wu